Research analysts at Leerink Partnrs cut their FY2024 earnings estimates for shares of Moderna in a note issued to investors ...

Analysts at Brookline Capital Management reduced their FY2024 EPS estimates for Moderna in a note issued to investors on Monday, January 13th. Brookline Capital Management analyst L. Cann now ...

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...

The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect ...

The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.

Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S. Department of Health and Human Services (HHS) to accelerate the development of mRNA-based pandemic influenza vaccines. The ...

Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for ...

Novo Nordisk said on Friday a late-stage trial with a high-dose version of its weight loss drug semaglutide helped overweight ...

CDC officials say medical professionals are seeing more patients whose illness cannot be traced back to an infected animal or ...

It was an extremely busy week in the biotech sector, with several companies making important presentations at the J.P. Morgan ...

Annemarie Hanekamp has overseen some of the most transformative changes in oncology over her years in Big Pharma. Now, she ...

Analysis of the S&P 500 health care sector's performance, quant ratings of top companies, and expert opinions on future ...